Welcome to our dedicated page for Hexo news (Ticker: HEXO), a resource for investors and traders seeking the latest updates and insights on Hexo stock.
HEXO Corp (HEXO) is a Health Canada-licensed leader in medical marijuana production, recognized for advanced cultivation methods and pharmaceutical-grade quality standards. This news hub provides investors and industry observers with essential updates on corporate milestones, regulatory compliance, and market developments.
Access timely reports on earnings announcements, facility expansions, and strategic partnerships that shape HEXO's position in the cannabis sector. Track innovations in product development and cultivation technologies through verified press releases and objective analysis.
Key coverage areas span financial results, regulatory updates, production capacity changes, and research initiatives. All content undergoes rigorous verification to ensure alignment with Health Canada's ACMPR framework and financial reporting standards.
Bookmark this page for direct access to HEXO's official communications, including material change reports and partnership announcements. Combine these updates with our historical data repository for comprehensive analysis of the company's evolving market strategy.
HEXO Corp announced that CEO Sebastien St-Louis will participate in a panel discussion titled “Predator or Prey? Navigating Canada’s Red Hot Cannabis M&A Sector” at MJBizCon today at 3 p.m. PT. The event will be available for live and on-demand viewing on the MJBizCon website. HEXO is a leading licensed producer in the cannabis market, holding a significant recreational market share in Canada through its brands like HEXO, Redecan, and more.
HEXO Corp (HEXO) will participate in the Benzinga Cannabis Capital Conference on October 15, 2021, in New York City and virtually. CFO Trent MacDonald will present at 1:30 p.m. ET and join the panel titled “Turning Focused Growth Strategies Into Expanded Market Share” at 4:25 p.m. ET. A live webcast of the presentation will be available on HEXO’s investor events page. HEXO is known for its diverse cannabis portfolio, recently increasing its market share in Canada with acquisitions of Redecan and 48North.
Truss CBD USA, a joint venture between Molson Coors and HEXO Corp, has expanded its Veryvell line of hemp-derived CBD beverages to 17 states across the U.S. after a successful launch in Colorado. Veryvell offers non-alcoholic, adaptogenic sparkling waters and beverage drops with broad spectrum hemp and less than 0.3% THC. The drinks, available online and in select stores, feature three flavors: Focus, Mind & Body, and Unwind, each infused with 20mg of CBD. This expansion reflects Molson Coors' strategy to diversify beyond beer.
HEXO Corp (TSX: HEXO; NASDAQ: HEXO) will participate in A.G.P.'s Virtual Fall Consumer Cannabis Conference on October 5, 2021, at 10:00 a.m. ET. CEO Sebastien St-Louis will discuss the Canadian market and the importance of innovation for growth. HEXO is a leading licensed cannabis producer in Canada, known for brands like HEXO, Redecan, and more. Following recent acquisitions, HEXO has strengthened its market position, serving both recreational and medical segments domestically and internationally. For further details, visit www.hexocorp.com.
HEXO Corp has achieved carbon neutrality as of September 2021, offsetting 25,965 tonnes of carbon emissions equivalent to 3.55 million plastic bottles. This initiative involved a partnership with Offsetters, supporting projects such as the Great Bear Forest Carbon Project in Canada and solar energy and forest conservation efforts globally. The company also emphasized its commitment to sustainability, aiming to reduce plastic use through collaborations with Dymapak and Plastic Bank. HEXO plans to extend its successful environmental strategies into the U.S. cannabis market.
HEXO Corp (TSX: HEXO; NASDAQ: HEXO) will participate in Citi’s 5th Annual Consumer Disruptive Growth Conference on September 21, 2021. CEO Sebastien St-Louis is set to join the panel titled 'Insider Perspectives on the CBD and Cannabis Landscape' at 11:20 a.m. ET. HEXO is recognized for its innovative cannabis products and holds a strong position in the Canadian recreational market, bolstered by recent acquisitions of Redecan and 48North. The company also operates in Canada, Israel, Malta, and Colorado, offering a diverse range of brands.
HEXO Corp. has successfully completed the acquisition of 48North Cannabis Corp. through a court-approved arrangement under the Canada Business Corporations Act. Each 48North shareholder will receive 0.02366 HEXO shares for every 48North share held. The 48North shares are expected to be de-listed from the TSX Venture Exchange on September 2, 2021. Shareholders must deposit their share certificates to receive HEXO shares. The newly listed 48North warrants will commence trading on the TSX under the symbol HEXO.WT.A on September 3, 2021.
HEXO Corp (TSX: HEXO; NASDAQ: HEXO) has completed its acquisition of Redecan, Canada's largest privately-owned licensed producer, for $400 million in cash and 69.7 million shares. This strategic move aims to strengthen HEXO's position in the Canadian cannabis market, targeting the top three global cannabis product companies. The deal includes an investor rights agreement with governance rights for Redecan's sellers and a 24-month hold period on the consideration shares. HEXO also expects to finalize its acquisition of 48North Cannabis Corp.
HEXO Corp has appointed Guillaume Jouët as Chief People & Culture Officer, effective September 8, 2021. In his new role, Jouët will focus on enhancing employee engagement to align with HEXO's corporate strategy. With over 20 years of international experience, including roles in various industries, he aims to develop a workforce that supports HEXO's growth. The appointment follows the recent hiring of Valerie Malone as Chief Commercial Officer, indicating a strengthened leadership team as HEXO expands its operations in Canada and globally.
HEXO Corp announced overwhelming shareholder support for its acquisition of Redecan, Canada’s largest privately-owned licensed producer, valued at $400 million. At the shareholders' meeting, 96.18% voted in favor of the transaction resolution, which includes issuing 69,721,116 common shares. Additionally, 94.99% approved a financing resolution for over 32 million shares tied to a $360 million secured note. All necessary regulatory approvals have been secured, and the transaction is expected to close soon, positioning HEXO as a potential leader in Canada’s cannabis market.